{"cik":2042347,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"Seaport Therapeutics, Inc.","units":{"USD":[{"end":"2025-12-31","val":4813000,"accn":"0001193125-26-260678","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-06-08"},{"end":"2025-12-31","val":4813000,"accn":"0001193125-26-329537","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-03","frame":"CY2025Q4I"},{"end":"2026-03-31","val":5066000,"accn":"0001193125-26-260678","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-06-08","frame":"CY2026Q1I"},{"end":"2026-06-30","val":4741000,"accn":"0001193125-26-329537","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-03","frame":"CY2026Q2I"}]}}